Review Article
Hodgkin's Disease in Patients with HIV Infection
Table 1
Results of prospective studies in HIV-HL.
| | Regimen/Reference | no. of patients | Stages III-IV | Response rate | Complete remission rate | Overall survival |
| | EBV [40] | 17 | 88% | 82% | 53% | 11 months | | EBVP [41] | 35 | 83% | 91% | 74% | 16 months | | ABVD [42] | 21 | 81% | 62% | 43% | 18 months | | ABVD [43[ | 8 | 75% | 100% | 100% | 43.5 months | | Stanford V [44] | 59 | 71% | 89% | 81% | 59% at 5 years | | BEACOPP [45] | 12 | 92% | 100% | 100% | 75% at 3 years | | ABVD [46] | 62 | 100% | 87% | 87% | 76% at 5 years | | VEBEP [48] | 71 | 70% | 78% | 67% | 69% at 2 years |
|
|
